Understanding Peptide Purity and Quality Analysis

Two vials can both be labeled 99% pure and still contain meaningfully different amounts of the peptide you ordered, without either label being wrong. "Purity" on a peptide label almost always refers to one specific measurement, chromatographic purity, and it answers a narrower question than most people assume. This guide explains what that number measures, what it leaves out, and which impurities matter most for research results.

What HPLC Purity Measures

Peptide purity is usually determined by reversed-phase high-performance liquid chromatography (RP-HPLC). The sample travels through a column packed with a hydrophobic stationary phase, and a gradient of rising organic solvent, typically acetonitrile with trifluoroacetic acid as an ion-pairing additive, elutes the components roughly in order of hydrophobicity [1]. A UV detector set to short wavelengths, where the peptide bond absorbs, records each component as a peak.

Purity is then reported as area percent: the area of the main peak divided by the total area of all detected peaks. A result of 99% means that 99% of the UV-absorbing material the method separated and detected eluted in the main peak. That definition has three built-in limits:

• It counts only what the detector sees. Water, inorganic salts and counter-ions such as trifluoroacetate or acetate are not part of the peak areas used to calculate purity.
• It separates only what the method can separate. An impurity that co-elutes with the main peak is counted as product, and forms that differ from the target by a single subtle change can be hard to resolve.
• It is relative, not absolute. Area percent says nothing about how many milligrams of peptide are in the vial.

Net Peptide Content: The Other Number

A lyophilized peptide is a salt. Basic groups on the chain, including the N-terminus and the side chains of lysine, arginine and histidine, pair with counter-ions, and the solid also holds residual water. Net peptide content is the fraction of the powder's weight that is actually peptide. It is measured by different methods than purity, such as quantitative amino acid analysis, elemental (CHN) analysis or Kjeldahl nitrogen determination.

Those methods are not equally reliable. In a comparison of four approaches for measuring the peptide content of lyophilized thymalfasin (thymosin alpha-1), amino acid analysis was highly variable in one laboratory while precise in another, HPLC results also depended on the laboratory, and CHN elemental analysis gave the most precise values, with a coefficient of variation below 2% [2].

A worked example

Consider an illustrative vial containing 10 mg of powder with 99% HPLC purity and 80% net peptide content. The mass of peptide material is 10 × 0.80 = 8.0 mg, and the mass of the correct sequence, excluding related impurities, is approximately 8.0 × 0.99 = 7.9 mg. A researcher who assumes 10 mg of target peptide will make solutions roughly a fifth weaker than intended. Neither figure was wrong; they measure different things. Whether a stated vial amount refers to gross powder or net peptide varies between suppliers, so it is worth confirming before calculating concentrations.

Where Impurities Come From

Research peptides are almost always made by solid-phase peptide synthesis, in which the chain is assembled one residue at a time on an insoluble resin support [3]. Each deprotection and coupling step is efficient but not perfect, and the by-products are structurally close to the target. A comprehensive review of related impurities in peptide medicines describes the main types [4]:

• Deletion sequences: a residue is missing, typically after an incomplete deprotection or coupling step. A single-residue deletion can behave almost identically to the target on HPLC.
• Insertion sequences: an extra residue added when excess amino acid reagent was carried into the next step.
• Truncated sequences: chains that stopped growing partway through the synthesis.
• Diastereomers from racemization: an L-amino acid converted to its D-form during synthesis, giving a product with exactly the same mass as the target.
• Protecting-group adducts: side-chain protecting groups that were not fully removed at the end of the synthesis.
• Oxidized forms and oligomers: oxidized side chains, and dimers or larger species.
• Degradation products: pyroglutamate, diketopiperazine and succinimide formation, and beta-elimination, which can occur during or after manufacture.

The review's authors stress that these impurities are not only a concern for approved drugs: they can strongly influence early functional studies and lead to erroneous conclusions [4]. A deletion analogue or a diastereomer may still bind the target receptor, act as a partial agonist or antagonist, or differ in potency. Unrelated peptides from poor manufacturing practice were also found as contaminants in some products [4].

Changes after synthesis

Some impurities form after the peptide leaves the synthesizer. Asparagine residues can deamidate through a succinimide intermediate, and in a classic model-peptide study that intermediate racemized with a half-time of 19.5 hours at 37 °C and pH 7.4, producing a mixture of L- and D-aspartyl and isoaspartyl products [5]. Deamidation changes the mass by only about 1 Da, and racemization does not change it at all, which is why a clean mass spectrum does not rule these forms out.

Counter-Ions: TFA and Acetate

Because trifluoroacetic acid is the standard additive in reversed-phase purification, peptides purified by HPLC are often isolated as trifluoroacetate (TFA) salts [6]. For many experiments that does not matter, but in cell culture it can. In a 1999 study, trifluoroacetate at 10^-8 to 10^-7 M reduced cell numbers and thymidine incorporation in fetal rat osteoblast cultures, with similar effects in articular chondrocytes and neonatal mouse calvariae [6]. When the TFA and hydrochloride salts of amylin, amylin-(1-8) and calcitonin were compared in osteoblasts, the TFA salts consistently produced less proliferation, enough to hide a real proliferative effect or suggest an antiproliferative one that was not there [6]. The authors recommended converting peptides to the hydrochloride or another biologically equivalent salt before biological testing [6].

Acetate and hydrochloride salts are the usual alternatives. A 2020 review of counter-ions in peptides describes how the choice of counter-ion affects a peptide's structure and physicochemical properties, and why that choice is a formulation decision in its own right [7]. Whatever the counter-ion, it adds weight to the powder and therefore lowers net peptide content.

Identity Is a Separate Question

HPLC purity says how much of the detected material sits in the main peak. It does not confirm that the main peak is the right peptide. Identity is established by mass spectrometry, which compares the observed molecular weight with the value calculated from the sequence, and which also flags common modifications: methionine oxidation adds 16 Da, and deamidation adds about 1 Da. A useful certificate of analysis therefore reports both a purity result and an identity result for the same lot. Our separate guide, How to Read a Peptide COA, walks through those documents line by line.

How Much Purity Does an Experiment Need?

There is no universal threshold, but the reasoning is straightforward. In receptor or cell-based assays, a 1% impurity that is a potent analogue of the target can contribute a measurable signal, especially at high test concentrations. Quantitative work such as binding constants or concentration-response curves warrants the highest purity available and a known net peptide content. Screening and qualitative work can tolerate more. In every case, recording the lot number used in each experiment lets you trace an unexpected result back to the material.

How Northbridge Approaches Purity

Northbridge Research Labs sends every batch for independent third-party testing. Published certificates of analysis are listed by lot, with test dates and purity results, on our COA page at /coa. Products do not ship with a printed certificate; the published documents are the reference.